ADBiotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,913	638.53	3,015	1,179	1,195
Short-Term Investments	630	630	630	4,547	120
Trading Asset Securities	6,926	410.72	5,769	2,901	1,465
Cash & Short-Term Investments	11,470	1,679	9,414	8,628	2,781
Cash Growth	583.01%	-82.16%	9.11%	210.28%	-2.17%
Accounts Receivable	1,961	2,930	1,596	1,873	3,497
Other Receivables	109.3	108.46	8.07	47.67	3.28
Receivables	5,989	3,039	1,604	2,321	3,500
Inventory	2,293	2,375	2,265	2,952	2,106
Prepaid Expenses	1,031	152.11	16.83	59.27	81.21
Other Current Assets	70.84	1,144	117.63	163.87	204.67
Total Current Assets	20,854	8,390	13,417	14,123	8,672
Property, Plant & Equipment	10,182	11,061	10,312	10,319	10,287
Long-Term Investments	1,785	1,923	1,585	6,491	1,878
Goodwill	-	704.45	1,126	-	-
Other Intangible Assets	31.69	898.15	1,029	2.4	5.11
Long-Term Accounts Receivable	0	-	-	-	0
Other Long-Term Assets	15,555	98.42	623.51	83	117.09
Total Assets	48,407	23,074	28,093	31,018	20,959
Accounts Payable	1,701	1,669	250.65	386.05	1,116
Accrued Expenses	417.87	336.03	212.78	250.12	341.01
Short-Term Debt	12,904	6,985	9,142	9,543	9,147
Current Portion of Long-Term Debt	831.64	653.96	399.08	166.56	773.78
Current Portion of Leases	37.98	60.72	89.38	21.09	19.92
Other Current Liabilities	13,749	3,797	1,174	1,426	1,229
Total Current Liabilities	29,641	13,501	11,268	11,793	12,626
Long-Term Debt	3,027	3,859	3,513	3,012	3,179
Long-Term Leases	0.77	413.32	466.24	28.1	49.18
Pension & Post-Retirement Benefits	57.35	47	71.92	-	-
Long-Term Deferred Tax Liabilities	303.68	483.29	205.32	-	-
Other Long-Term Liabilities	0	0	0	-	-
Total Liabilities	33,031	18,304	15,525	14,833	15,854
Common Stock	8,180	4,570	4,570	4,570	3,847
Additional Paid-In Capital	35,617	25,557	27,257	27,257	18,293
Retained Earnings	-27,672	-24,381	-16,431	-13,574	-16,270
Comprehensive Income & Other	-802.69	-909.44	-2,004	-2,068	-763.03
Total Common Equity	15,323	4,837	13,393	16,185	5,106
Minority Interest	-1,783	-1,862	-2,545	-	-
Shareholders' Equity	15,377	4,771	12,569	16,185	5,106
Total Liabilities & Equity	48,407	23,074	28,093	31,018	20,959
Total Debt	16,802	11,972	13,610	12,771	13,168
Net Cash (Debt)	-5,332	-10,292	-4,196	-4,143	-10,388
Net Cash Per Share	-443.82	-1126.04	-459.08	-410.96	-1351.57
Filing Date Shares Outstanding	14.4	9.14	9.14	9.14	7.69
Total Common Shares Outstanding	14.4	9.14	9.14	9.14	7.69
Working Capital	-8,788	-5,111	2,149	2,330	-3,954
Book Value Per Share	1063.73	529.16	1465.20	1770.73	663.67
Tangible Book Value	15,291	3,234	11,237	16,183	5,100
Tangible Book Value Per Share	1061.53	353.83	1229.37	1770.47	663.00
Land	5,446	5,321	3,868	3,868	641.06
Buildings	4,061	4,192	4,323	4,455	4,586
Machinery	489.7	967.43	1,411	1,729	2,201
Construction In Progress	25.6	-	14.4	117.47	2,784

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.